BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28606965)

  • 21. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.
    da Cunha VR; Brenol CV; Brenol JC; Fuchs SC; Arlindo EM; Melo IM; Machado CA; de Castro Chaves H; Xavier RM
    Scand J Rheumatol; 2012 May; 41(3):186-91. PubMed ID: 22416768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular outcomes in male veterans with rheumatoid arthritis.
    Banerjee S; Compton AP; Hooker RS; Cipher DJ; Reimold A; Brilakis ES; Banerjee P; Kazi S
    Am J Cardiol; 2008 Apr; 101(8):1201-5. PubMed ID: 18394459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis.
    Kastbom A; Ärlestig L; Rantapää-Dahlqvist S
    J Rheumatol; 2015 Oct; 42(10):1740-5. PubMed ID: 26178285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
    Sandberg ME; Bengtsson C; Källberg H; Wesley A; Klareskog L; Alfredsson L; Saevarsdottir S
    Ann Rheum Dis; 2014 Nov; 73(11):2029-33. PubMed ID: 24818635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
    Ocon AJ; Reed G; Pappas DA; Curtis JR; Kremer JM
    Ann Rheum Dis; 2021 Dec; 80(12):1522-1529. PubMed ID: 34215644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
    Liao KP; Liu J; Lu B; Solomon DH; Kim SC
    Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Appiah D; Schreiner PJ; MacLehose RF; Folsom AR
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2700-6. PubMed ID: 26494231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
    Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
    J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.
    Barra LJ; Pope JE; Hitchon C; Boire G; Schieir O; Lin D; Thorne CJ; Tin D; Keystone EC; Haraoui B; Jamal S; Bykerk VP;
    Rheumatology (Oxford); 2017 May; 56(5):768-776. PubMed ID: 28073956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study.
    Nikiphorou E; de Lusignan S; Mallen CD; Khavandi K; Bedarida G; Buckley CD; Galloway J; Raza K
    Heart; 2020 Oct; 106(20):1566-1572. PubMed ID: 32209618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
    Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
    Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: comparison of two cohorts treated according to different treat-to-target protocols.
    Balduzzi S; Scirè CA; Sakellariou G; Benaglio F; Bugatti S; Montecucco C; Caporali R
    Clin Exp Rheumatol; 2017; 35(3):401-405. PubMed ID: 27974097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
    Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
    Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study.
    Chiu HY; Huang HL; Li CH; Chen HA; Yeh CL; Chiu SH; Lin WC; Cheng YP; Tsai TF; Ho SY
    PLoS One; 2015; 10(9):e0136508. PubMed ID: 26406879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular death in rheumatoid arthritis: a population-based study.
    Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.
    Kapetanovic MC; Lindqvist E; Simonsson M; Geborek P; Saxne T; Eberhardt K
    Scand J Rheumatol; 2010; 39(5):353-9. PubMed ID: 20615160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
    Eriksson JK; Jacobsson L; Bengtsson K; Askling J
    Ann Rheum Dis; 2017 Feb; 76(2):364-370. PubMed ID: 27283333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.
    Crowson CS; Rollefstad S; Ikdahl E; Kitas GD; van Riel PLCM; Gabriel SE; Matteson EL; Kvien TK; Douglas K; Sandoo A; Arts E; Wållberg-Jonsson S; Innala L; Karpouzas G; Dessein PH; Tsang L; El-Gabalawy H; Hitchon C; Ramos VP; Yáñez IC; Sfikakis PP; Zampeli E; Gonzalez-Gay MA; Corrales A; Laar MV; Vonkeman HE; Meek I; Semb AG;
    Ann Rheum Dis; 2018 Jan; 77(1):48-54. PubMed ID: 28877868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.